Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hims & Hers vs HumeCare+

Hims & Hers
Graded #57

Higher grade

vs+17
HumeCare+
Graded #319

Lower grade

The verdict

Hims & Hers takes it — 75.6/100 to 58.6/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +28
82
54
Dose & formulationHims & Hers +26
78
52
Clinical oversightHumeCare+ +16
55
71
Labs & monitoringHims & Hers +27
80
53
FulfillmentHims & Hers +20
84
64
Contract termsHims & Hers +19
80
61
Hims & Hers · left barHumeCare+ · right bar

The numbers

MetricHims & HersHumeCare+
WeighScore75.6/10058.6/100
GradeCC
Scorecard rank#57#319
Semaglutide$199/mo$199/mo (a floor, not a price: plus a separate fee at enrollment and every refill, non-refundable and never published; no dose stated, compounded)
TirzepatideNot disclosed$299/mo (visible only after the medical intake; plus a separate fee at enrollment and every refill, never published; no dose stated, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Hims & Hers

Graded #57 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny
HumeCare+

Graded #319 · C

Strengths

  • Pairs compounded semaglutide with continuous body-composition tracking (lose fat, preserve muscle)
  • Includes a Hume Pod body-composition device at no extra cost
  • Billed monthly with no minimum term — the plan renews month to month and can be canceled before the renewal date, in a category full of three- and six-month prepays
  • Backed by Hume Health, an established body-composition scale brand
  • Clinician-prescribed and monitored with weekly tracking

Where it loses points

  • The advertised $199 is a floor rather than the price: its terms charge a non-refundable clinical consultation fee at enrollment AND at every refill, never state what that fee is, and add that dosages or formulations may carry further charges at the company's sole discretion
  • Final medication pricing is gated behind an intake quiz
  • Only semaglutide is shown on the marketing site (tirzepatide not confirmed)
  • Prescribing medical group and pharmacy partner not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard